Dawn L. Hershman
2 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Ruxolitinib in Combination With Trastuzumab in Metastatic HER2 Positive Breast Cancer (NCT02066532) | Dawn L. Hershman | 2014-06-01 |
| Glucosamine and Chondroitin for Aromatase Inhibitor Induced Joint Symptoms in Women With Breast Cancer (NCT00691678) | Dawn L. Hershman | 2008-10-01 |
Track Dawn L. Hershman automatically
Every clearance here is in the API, with alerts when new ones post.